raplixa
mallinckrodt pharmaceuticals ireland limited - human fibrinogen, human thrombin - hemostasis, surgical - antihemorrhagics - supportive treatment where standard surgical techniques are insufficient for improvement of haemostasis.raplixa must be used in combination with an approved gelatin sponge.raplixa is indicated in adults over 18 years of age.
mallinckrodt pharmaceuticals therakos™ cellex™ photopheresis system
transmedic pte ltd - general hospital - indicated for the administration of photopheresis.
therakos cellex photopheresis system light assembly - photopheresis system lamp assembly
ikaria australia pty ltd - 46914 - photopheresis system lamp assembly - therakos? cellex? photopheresis system lamp assembly is indicated for extracorporeal photopheresis (reusable)
therakos cellex photopheresis system - photopheresis system
ikaria australia pty ltd - 46912 - photopheresis system - the therakos? cellex? photopheresis system instrument systems are indicated for the administration of photopheresis.
photopheresis system blood set
ikaria australia pty ltd - 46913 - photopheresis system blood set - therakos? cellex? photopheresis system procedural kit is indicated for extracorporeal photopheresis (single use)
fentanyl (astrazeneca)
juno pharmaceuticals nz limited - fentanyl citrate 78.125 µg/ml equivalent to to 50 µg/ml of fentanyl - solution for injection - 50 mcg/ml - active: fentanyl citrate 78.125 µg/ml equivalent to to 50 µg/ml of fentanyl excipient: citric acid sodium chloride sodium citrate dihydrate sodium hydroxide as 2m solution for ph adjustment water for injection
paracetamol
douglas pharmaceuticals limited - paracetamol 500mg (compap l coarse; proprietary info. mallinckrodt tt60-59-7-2) - tablet - 500 mg - active: paracetamol 500mg (compap l coarse; proprietary info. mallinckrodt tt60-59-7-2)
acthar- repository corticotropin injection
mallinckrodt ard llc - corticotropin (unii: k0u68q2txa) (corticotropin - unii:k0u68q2txa) - corticotropin 80 [usp'u] in 1 ml - acthar gel is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. acthar gel is indicated for the treatment of acute exacerbations of multiple sclerosis in adults. controlled clinical trials have shown acthar gel to be effective in speeding the resolution of acute exacerbations of multiple sclerosis. however, there is no evidence that it affects the ultimate outcome or natural history of the disease. as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy); ankylosing spondylitis. during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus, systemic dermatomyositis (polymyositis). severe erythema multiforme, stevens-johnson syndrome. serum sickness. severe acute and chronic allergic and inflammatory processes involvin
pamelor- nortriptyline hydrochloride capsule
specgx llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg - pamelor™ (nortriptyline hcl) is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. monoamine oxidase inhibitors (maois) the use of maois intended to treat psychiatric disorders with pamelor or within 14 days of stopping treatment with pamelor is contraindicated because of an increased risk of serotonin syndrome. the use of pamelor within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting pamelor in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and administration ). hypersensitivity to tricyclic antidepressants cross-sensitivity between pamelor and other dibenzazepines is a possibility. myocardial infarction pamelor is contraindicated during the acute recovery period after myoc
mallinckrodt dar aerosol oxygen therapy nebulizer
covidien private limited - general hospital - it is intended for aerosol administration, and it can be used with different accessories; face, tracheostomy and tent masks; mouth piece and antibacterial filter, which limits the release in the environment of drugs and possible infective agents.